Determinants of COVID-19 Disease Severity in Patients with Cancer

Determinants of COVID-19 disease severity in patients with cancer – Nature Medicine

Commentaries: New York City data suggest link between immunotherapy, poor COVID-19 outcomes – Medwire News AND Should You Delay Cancer Treatment Because of COVID-19? Study Says Most Treatments Don’t Worsen Coronavirus Infection – Memorial Sloan Kettering

Related Commentary on Twitter

Publication of MSKCC COVID-19 experience shows that receiving ICIs seems to be associated with both increased risk of hospitalization with COVID-19 (HR 2.84; P = 0.013) and severe respiratory illness (HR 2.74; P = 0.004) https://t.co/GEU4GMVT8e

— NatureRevClinOncol (@NatRevClinOncol) July 2, 2020